Cargando…

Editorial: Targeting signalling pathways in inflammatory diseases

Detalles Bibliográficos
Autores principales:	Baig, Mirza S., Thurston, Teresa L. M., Sharma, Rahul, Atre, Rajat, Saqib, Uzma, Khabiya, Rakhi, Bharti, Shreya, Poh, Chit L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431928/ https://www.ncbi.nlm.nih.gov/pubmed/37593741 http://dx.doi.org/10.3389/fimmu.2023.1241440

Ejemplares similares

TIRAP in the Mechanism of Inflammation
por: Rajpoot, Sajjan, et al.
Publicado: (2021)

Simultaneous targeting of MyD88 and Nur77 as an effective approach for the treatment of inflammatory diseases
por: Uzma, Saqib, et al.
Publicado: (2016)

Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells
por: Baig, Mirza S., et al.
Publicado: (2020)

Implications of metabolic dysfunction associated fatty liver disease in COVID-19
por: Chakraborty, Raja, et al.
Publicado: (2023)

Editorial: Role of Neutrophils in Inflammatory Diseases
por: Marichal, Thomas, et al.
Publicado: (2020)

Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses
por: Li, Jiajing, et al.
Publicado: (2023)

Editorial: Multiple Implications of the Kynurenine Pathway in Inflammatory Diseases: Diagnostic and Therapeutic Applications
por: Mándi, Yvette, et al.
Publicado: (2022)

Editorial: Inflammatory and inflammatory-like responses in insects
por: Goto, Akira, et al.
Publicado: (2023)

Editorial: Inflammatory Signaling in Bone Marrow Failure and Hematopoietic Malignancy
por: Trompouki, Eirini, et al.
Publicado: (2017)

The Role of Histamine and Histamine Receptors in Mast Cell-Mediated Allergy and Inflammation: The Hunt for New Therapeutic Targets
por: Thangam, Elden Berla, et al.
Publicado: (2018)

Editorial: Non-canonical NF-κB signaling in immune-mediated inflammatory diseases and malignancies
por: Tas, Sander W., et al.
Publicado: (2023)

Editorial: Global excellence in inflammatory diseases: North America 2021
por: Kusner, Linda L., et al.
Publicado: (2023)

Editorial: Termination of pro-inflammatory signaling and its dysregulation in autoimmune diseases
por: Huber, René, et al.
Publicado: (2023)

Editorial: Intestinal Dysbiosis in Inflammatory Diseases
por: de Oliveira, Gislane Lelis Vilela, et al.
Publicado: (2021)

Editorial: Inflammatory Mechanisms of Hemolytic Diseases
por: Sesti-Costa, Renata, et al.
Publicado: (2022)

Editorial: Microbiota in skin inflammatory diseases
por: Park, Eun Jeong, et al.
Publicado: (2023)

Phytochemicals as modulators of M1-M2 macrophages in inflammation
por: Saqib, Uzma, et al.
Publicado: (2018)

Editorial: Death Receptors, Non-apoptotic Signaling Pathways and Inflammation
por: Szegezdi, Eva, et al.
Publicado: (2020)

Editorial: Signaling pathways behind immune evasion and therapy resistance
por: Martin-Orozco, Elena, et al.
Publicado: (2022)

Editorial: The Roles of Checkpoint Inhibitors in Inflammatory Diseases
por: von Knethen, Andreas, et al.
Publicado: (2021)

Editorial: Metabolic conditions of chronic inflammatory diseases
por: Saalbach, Anja, et al.
Publicado: (2022)

Editorial: JAK inhibition in autoimmune and inflammatory diseases
por: Telliez, Jean-Baptiste, et al.
Publicado: (2022)

Cigarette Smoke Amplifies Inflammatory Response and Atherosclerosis Progression Through Activation of the H1R-TLR2/4-COX2 Axis
por: Barua, Rajat S., et al.
Publicado: (2015)

Editorial: Post-translational modifications of extracellular signaling molecules and antigens in immune and inflammatory responses
por: Afonina, Inna S., et al.
Publicado: (2022)

Editorial: Inhibitory Receptors and Pathways of Lymphocytes
por: Carmo, Alexandre M., et al.
Publicado: (2020)

Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies
por: Bianchi, Elisabetta, et al.
Publicado: (2021)

Editorial: Antimicrobial Peptides and Complement – Maximising the Inflammatory Response
por: Stover, Cordula M.
Publicado: (2015)

Editorial: Microbial and Environmental Factors in Autoimmune and Inflammatory Diseases
por: Arleevskaya, Marina I., et al.
Publicado: (2017)

Editorial: The Role of the Gut Microbiota in Health and Inflammatory Diseases
por: Mangalam, Ashutosh K., et al.
Publicado: (2020)

Editorial: Interferon-λs: New Regulators of Inflammatory Processes
por: Zanoni, Ivan, et al.
Publicado: (2019)

Editorial: Immunity and Inflammatory Response in Kidney Stone Disease
por: Thongboonkerd, Visith, et al.
Publicado: (2021)

Editorial: Mitochondria at the Crossroads of Immunity and Inflammatory Tissue Damage
por: Nunes, João Paulo Silva, et al.
Publicado: (2021)

Editorial: Extracellular Vesicles as Immunomodulatory Mediators in Inflammatory Processes
por: Donate, Paula Barbim, et al.
Publicado: (2022)

Editorial: Regulation of osteoclast differentiation in autoimmune and inflammatory diseases
por: Lee, Sun-Kyeong, et al.
Publicado: (2023)

Editorial: Immunomodulatory role of metalloproteases in chronic inflammatory diseases
por: Yang, Guan-Jun, et al.
Publicado: (2023)

Editorial: Role of stem cell derivatives in inflammatory diseases
por: Zhang, Cuiping, et al.
Publicado: (2023)

Editorial: Dual role of inflammatory mediators in cancer immunotherapy
por: Wang, Xiaoli, et al.
Publicado: (2023)

Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2
por: Ohishi, Tomokazu, et al.
Publicado: (2022)

Targeting the Notch Signaling Pathway in Chronic Inflammatory Diseases
por: Christopoulos, Panagiotis F., et al.
Publicado: (2021)

Editorial: Innate Immunity Pathways in Autoimmune Diseases
por: Zouali, Moncef, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ta42b1bopdm165ndgleaihr5io